{"url_path":"/sec/eltp/10-k/2026/item-5","section_key":"item-5","section_title":"Item 5 MARKET FOR COMPANY’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES**","topic":"sec","document":{"doc_type":"10-K","doc_date":"2026-06-29","source_url":"https://www.sec.gov/Archives/edgar/data/1053369/0001493152-26-031070-index.html","accession_number":"0001493152-26-031070","cik":"0001053369","ticker":"ELTP","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","edgar_url":"https://www.sec.gov/Archives/edgar/data/1053369/0001493152-26-031070-index.html","primary_entity_key":"0001053369","primary_entity_name":"ELITE PHARMACEUTICALS INC /NV/"},"word_count":1660,"has_tables":true,"body_markdown":"**ITEM\n5. MARKET FOR COMPANY’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES**\n\n \n\n**Market\nInformation**\n\n \n\nOur\nCommon Stock is quoted on the OTCQB under the ticker symbol “ELTP”.\n\n \n\n**Holders**\n\n \n\nAs\nof June 25, 2026, there were approximately 105 holders of record of our Common Stock.\n\n \n\n**Dividends**\n\n \n\nWe\nhave never paid cash dividends on our Common Stock. We currently anticipate that we will retain all available funds for use in the operation\nand expansion of our business.\n\n \n\n**Recent\nSales of Unregistered Securities**\n\n \n\nNone.\n\n \n\n**Securities\nAuthorized for Issuance under Equity Compensation Plans**\n\n \n\nThe\nfollowing table sets forth certain information regarding Elite’s equity compensation plans as of March 31, 2026:\n\n \n\nPlan Category \n\n**Number of securities to**\n\n**be issued upon**\n\n**exercise of outstanding**\n\n**options, warrants,**\n\n**and rights**\n\n**(a)**\n  \n\n**Weighted-average**\n\n**exercise price per share**\n\n**of outstanding options,**\n\n**warrants, and rights**\n\n**(b)**\n  \n\n**Number of securities**\n\n**remaining available**\n\n**for future issuance**\n\n**under equity**\n\n**compensation plans**\n\n**(excluding securities**\n\n**reflected in column (a))**\n \n\nEquity compensation plans approved by security holders (1) \n 6,906,666  \n$0.07  \n — \n\nEquity compensation plans not approved by security holders (2) \n —  \n —  \n 80,000,000 \n\nTotal \n 6,906,666  \n —  \n 80,000,000 \n\n \n\n(1)\nRepresents securities reserved and granted under the 2014 Equity Incentive Plan\n\n \n \n\n(2)\nRepresents securities reserved and available for grant under the 2024 Equity Incentive Plan\n\n \n\n**2014\nEquity Incentive Plan**\n\n \n\nOur\n2014 Equity Incentive Plan (the “2014 Plan”) was adopted by the Board on March 17, 2014, to attract, motivate and retain\nofficers, employees, consultants, and directors by issuing common stock-based incentives to directors, officers, employees, and consultants\nwho are selected for participation. By linking incentive compensation to increases in shareholder value, it is hoped that these individuals\nwill both continue in the long-term service of the Company and be motivated to experience a heightened interest and participate in the\nfuture success of Company operations. An aggregate of 15,730,000 shares of Common Stock were initially reserved for grant and issuance\npursuant to the 2014 Plan. The 2014 Plan is administered and interpreted by our Compensation Committee (the “Administrator”).\nAwards under the 2014 Plan may be granted in any one or all of the following forms: (i) incentive stock options (“ISOs”)\nintended to qualify under Section 422 of the Internal Revenue Code of 1986, as amended (the “Code”); (ii) non-qualified stock\noptions (“NSOs”); (iii) stock appreciation rights, which may be granted in tandem with options or on a stand-alone basis;\n(iv) shares of restricted stock; (v) shares of unrestricted stock; (vi) performance shares, and (vii) performance units.\n\n \n\nOptions\nmay not be granted under the 2014 Plan at an exercise price of less than the fair market value of the common stock on the date of grant\nand the term of options cannot exceed ten years. ISOs may only be granted to persons who are employees of the Company. The exercise price\nof an ISO granted to a holder of more than 10% of the common stock must be at least 110% of the fair market value of the common stock\non the date of grant, and the term of these options cannot exceed five years.\n\n \n\n47\n\n \n\n \n\nThe\nAdministrator also may grant stock appreciation rights. Stock appreciation rights represent the right to receive upon exercise an amount\npayable in cash or common stock equal to (A) the number of shares with respect to which the stock appreciation right is being exercised\nmultiplied by (B) the excess of (i) the fair market value of a share of common stock on the date the award is exercised over (ii) the\nexercise price specified in the award agreement.\n\n \n\nUnder\nthe performance award component of the 2014 Plan, participants may be granted an award denominated in shares of common stock or in dollars.\nAchievement of the performance targets, or multiple performance targets established by the Administrator relating to corporate, group,\nunit or individual performance based upon standards set by the Administrator shall entitle the participant to payment at the full amount\nor a portion of the amount specified with respect to the award, at the discretion of the Administrator based on its evaluation of the\nperformance of the target goals applicable to such award. Payment may be made in cash, common stock or any combination thereof, as determined\nby the Administrator, and shall be adjusted in the event the participant ceases to be an employee of the Company before the end of a\nperformance cycle by reason of death, disability, or retirement.\n\n \n\nUnder\nthe stock component of the 2014 Plan, the Administrator may, in selected cases, grant to a plan participant a given number of shares\nof restricted stock or unrestricted stock. Restricted stock under the 2014 Plan is common stock restricted as to sale pending fulfillment\nof such vesting schedule and employment requirements as the Administrator shall determine. Prior to the lifting of the restrictions,\nthe participant will nevertheless be entitled to receive distributions in liquidation and dividends on, and to vote the shares of, the\nrestricted stock. The 2014 Plan provides for forfeiture of restricted stock for breach of conditions of grant.\n\n \n\nThe\n2014 Plan also permits the board of directors (and not the Compensation Committee) to grant awards of NSOs, restricted stock or unrestricted\nstock to non-employee directors. The board may authorize individual grants or adopt one or more formulas for grants of awards to the\nnon-employee directors. All options granted to non-employee directors must have an exercise price equal to the fair market value at the\ndate of grant.\n\n \n\nThe\nexercise price of awards may be paid in cash, in shares of common stock (valued at fair market value at the date of exercise), by delivery\nof a notice of exercise together with irrevocable instructions to a broker to deliver to the Company the proceeds of the sale of common\nstock or of a loan from the broker sufficient to pay the exercise price, by having the Company withhold from shares being exercised the\nnumber of shares having a fair market value equal to the exercise price for all shares being exercised, or by a combination of the foregoing\nmeans of payment, as may be determined by the Administrator.\n\n \n\nThe\n2014 Plan expired on March 17, 2024.\n\n \n\n**2024\nEquity Incentive Plan**\n\n \n\nOur\n2024 Equity Incentive Plan (the “2024 Plan”) was adopted by the Board on March 27, 2024, to enhance the Company’s and\nits Affiliates’ ability to attract and retain highly qualified employees, officers, Non-Employee Directors, and Consultants, and\nto motivate such employees, officers, Non-Employee Directors, and Consultants to serve the Company and its Affiliates and to expend maximum\neffort to improve the business results and earnings of the Company, by providing to such persons an opportunity to acquire or increase\na direct proprietary interest in the operations and future success of the Company. To this end, the 2024 Plan provides for the grant\nof Options, Stock Appreciation Rights (“SAR”), Restricted Stock, Restricted Stock Units, and Other Stock-based Awards. Any\nof these Awards may, but need not, be made as performance incentives to reward attainment of performance goals in accordance with the\nterms hereof. Options may only be granted as NSOs and will not qualify as ISOs. Upon becoming effective, the Plan replaced, and no further\nawards shall be made under, the 2014 Plan.\n\n \n\nEach\noption granted under the 2024 Plan shall be an NSO, with such being defined as an option to purchase shares of Common Stock that does\nnot meet the criteria of an incentive stock option within the meaning of Section 422 of Code. The exercise price for share of Common\nStock subject to an option shall be fixed by the Board and shall be at least the fair market value of a share of Common Stock on the\ngrant date, provided that in no case shale the option price be less than the par value of a share of Common Stock.\n\n \n\nA\nSAR shall confer on the participant a right to receive, upon exercise thereof, the excess of the fair market value of one share of Common\nStock on the date of exercise over the SAR exercise price, as determined by the Board. The award agreement for a SAR shall specify the\nSAR exercise price, which shall be fixed on the grant date as not less than the fair market value of a share of Common Stock on that\ndate, provided, however that the SAR’s grant price may not be less than the fair market value of a share of Common Stock on the\ngrant date of the SAR to the extent required by Section 409A of the Code.\n\n \n\nUnder\nthe restricted stock and restricted stock units component of the 2024 Plan, the Board may award grants of share of Common Stock or bookkeeping\nentries representing the equivalent shares of Common Stock with restrictions determined by the Board, which include, without limitation,\na restricted period of time and the satisfaction of corporate or individual performance objectives.\n\n \n\nPayment\nof the option price for shares purchased pursuant to the exercise of an option, or the purchase price for restricted stock shall be made\nin cash or in cash equivalents acceptable to the Company, except that with respect to an option only, to the extent permitted by law\nand to the extent the option award agreement so provides, payment of the option price may be made all or in part by delivery (on a form\nacceptable to the Company) of an irrevocable direction to a licensed securities broker acceptable to the Company to sell shares of Common\nStock and to deliver all or part of the sales proceeds to the Company in payment of the option price and any withholding taxes required\nunder applicable laws.\n\n \n\nThe\n2024 Plan provides for the Board’s granting of other stock based awards in addition to or in conjunction with other awards under\nthe 2024 Plan. Such other stock based awards may be used in the settlement of amounts payable in shares of Common Stock under any other\ncompensation plan or arrangement of the Company.\n\n \n\n48\n\n \n\n \n\n**Issuer\nPurchases of Equity Securities**\n\n** **\n\nNone."}